Clinical Trial Update: PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM) [Phase 2]

View source ↗

Summary

Phase 2 study of PROCHYMAL (remestemcel-L), an adult stem cell therapy, for recently diagnosed Type 1 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• PROCHYMAL (allogeneic mesenchymal stem cells)

Snippet

Sponsor: Mesoblast, Inc. | Conditions: Type 1 Diabetes Mellitus, Type 1 Diabetes | Phase 2 | Status: COMPLETED